Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-3-23
pubmed:abstractText
Innate immunity plays an important role in pulmonary host defense against Pneumocystis carinii, an important pathogen in individuals with impaired cell-mediated immunity. We investigated the role of GM-CSF in host defense in a model of P. carinii pneumonia induced by intratracheal inoculation of CD4-depleted mice. Lung GM-CSF levels increased progressively during the infection and were significantly greater than those in uninfected controls 3, 4, and 5 wk after inoculation. When GM-CSF gene-targeted mice (GM-/-) depleted of CD4+ cells were inoculated with P. carinii, the intensities of infection and inflammation were increased significantly compared with those in CD4-depleted wild-type mice. In contrast, transgenic expression of GM-CSF directed solely in the lungs of GM-/- mice (using the surfactant protein C promoter) dramatically decreased the intensity of infection and inflammation 4 wk after inoculation. The concentrations of surfactant proteins A and D were greater in both uninfected and infected GM-/- mice compared with those in wild-type controls, suggesting that this component of the innate response was preserved in the GM-/- mice. However, alveolar macrophages (AM) from GM-/- mice demonstrated impaired phagocytosis of purified murine P. carinii organisms in vitro compared with AM from wild-type mice. Similarly, AM production of TNF-alpha in response to P. carinii in vitro was totally absent in AM from GM-/- mice, while GM-CSF-replete mice produced abundant TNF in this setting. Thus, GM-CSF plays a critical role in the inflammatory response to P. carinii in the setting of impaired cell-mediated immunity through effects on AM activation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
164
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2602-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10679099-Animals, pubmed-meshheading:10679099-Cells, Cultured, pubmed-meshheading:10679099-Genetic Predisposition to Disease, pubmed-meshheading:10679099-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:10679099-Immunity, Innate, pubmed-meshheading:10679099-Lung, pubmed-meshheading:10679099-Macrophages, Alveolar, pubmed-meshheading:10679099-Mice, pubmed-meshheading:10679099-Mice, Inbred BALB C, pubmed-meshheading:10679099-Mice, Inbred C57BL, pubmed-meshheading:10679099-Mice, Nude, pubmed-meshheading:10679099-Mice, Transgenic, pubmed-meshheading:10679099-Phagocytosis, pubmed-meshheading:10679099-Pneumocystis, pubmed-meshheading:10679099-Pneumonia, Pneumocystis, pubmed-meshheading:10679099-Proteolipids, pubmed-meshheading:10679099-Pulmonary Surfactants, pubmed-meshheading:10679099-Tumor Necrosis Factor-alpha
pubmed:year
2000
pubmed:articleTitle
Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
pubmed:affiliation
Division of Pulmonary and Critical Care Medicine, University of Michigan, and Department of Veterans Affairs Medical Center, Ann Arbor, MI 48105, USA. rpaine@umich.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't